CVE-2026-21974 is a medium-severity vulnerability affecting the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications. Specifically, the vulnerability impacts version 7.0.1.0, which is known to be easily exploitable. An unauthenticated attacker with network access via HTTP can successfully compromise the application, leading to unauthorized read access to sensitive data. The CVSS 3.1 base score for this vulnerability is 5.3, indicating a moderate level of risk, specifically with confidentiality impacts.
Organizations utilizing the affected version should be aware that the vulnerability can be exploited remotely without requiring any authentication. This makes it particularly concerning for organizations in sectors that rely on critical data managed by Oracle applications. Given the potential implications, organizations should prioritize patching immediately.
The urgency to address this vulnerability is emphasized by its potential to expose sensitive data, which could lead to significant reputational damage and compliance implications. As of now, there are no known exploits publicly available, but organizations should remain vigilant.
In summary, CVE-2026-21974 requires immediate attention. Failure to address this vulnerability may result in unauthorized access, leading to data breaches that could have far-reaching consequences.
Vulnerability Details
The CVE-2026-21974 vulnerability is characterized by an easily exploitable weakness within Oracle Life Sciences Central Designer. The official description states that it allows an unauthenticated attacker with network access to compromise the application. The vulnerability falls under the CWE-200 classification, which signifies improper handling of sensitive information.
The CVSS score of 5.3 indicates a medium severity level, with the following metrics: Attack Vector (AV) is NETWORK, Attack Complexity (AC) is LOW, Privileges Required (PR) is NONE, and User Interaction (UI) is NONE. The impacts are primarily on confidentiality, while integrity and availability remain unaffected.
This vulnerability was published on January 20, 2026. Organizations are encouraged to review their systems and apply necessary patches to mitigate risks associated with this vulnerability.
Technical Analysis
The root cause of CVE-2026-21974 lies in the way Oracle Life Sciences Central Designer handles authentication and access controls. Attackers may leverage this vulnerability through network access without requiring any prior authentication. The attack complexity is classified as low, making it easier for potential attackers to exploit the vulnerability.
The attack vector is network-based, indicating that the potential for exploitation exists from any device that can connect to the affected system over HTTP. Since no user interaction is required, automated attacks could be executed to exploit this vulnerability.
In terms of impacts, the confidentiality of data is at risk, as attackers may gain unauthorized read access to sensitive information. The integrity and availability of the system remain unaffected, indicating that an attacker may not be able to modify or disrupt service functionality.
Risk & Impact Analysis
The real-world risk of CVE-2026-21974 is significant. Organizations using the affected version of Oracle Life Sciences Central Designer may find themselves at risk of data breaches and unauthorized access to sensitive information. Given the nature of data handled by these applications, the potential for reputational damage and compliance violations is substantial.
The vulnerability's moderate CVSS score suggests that while it may not be the highest threat, it still requires prioritization, especially considering the ease of exploitation. Organizations should assess their exposure and ensure that necessary security measures are in place.
With the vulnerability being listed in the CVE database, organizations should act promptly to patch affected systems. The blast radius of this vulnerability could extend beyond the immediate systems if attackers gain a foothold, leading to further exploitation of networked systems.
Exploitation Status
Signal | Status |
|---|---|
Known Exploit | No |
Public PoC | No |
Actively Exploited | No |
Ransomware Use | No |
Affected Versions
The only affected version of the Oracle Life Sciences Central Designer is 7.0.1.0. Organizations running this version should ensure that they apply the necessary patches to mitigate the risks associated with this vulnerability.
Mitigation & Remediation
Organizations should prioritize patching the Oracle Life Sciences Central Designer to version 7.0.1.1 or later, as recommended by Oracle in their advisory. If patches are not immediately available, organizations must implement additional security measures such as restricting network access to the application and monitoring access logs for unusual activity.
Furthermore, organizations should conduct a thorough assessment of their current security posture and consider engaging in regular security testing, such as penetration testing to identify potential vulnerabilities in their applications.
Detection Guidance
To detect potential exploitation attempts of CVE-2026-21974, organizations should monitor logs for unusual access patterns, especially attempts to access sensitive data without proper authentication. Behavioral anomalies, such as sudden spikes in access requests, can also indicate attempted exploitation.
Additionally, establishing network signatures that flag unauthorized access attempts can help in early detection of exploitation attempts. Organizations should also review system changes and access logs regularly to ensure that no unauthorized changes are made.
AppSecure Threat Intelligence Insight
CVE-2026-21974 highlights the ongoing challenges organizations face in securing applications that manage sensitive data. The vulnerability represents a pattern of increasing attacks targeting web applications with inadequate access controls.
Security teams should take this incident as a strategic reminder of the importance of regular security assessments and the implementation of robust access controls. Organizations are encouraged to adopt a proactive security posture and to stay informed about emerging threats.
For further information on securing applications, organizations can refer to resources such as the vulnerability management program, best practices in penetration testing methodology, and the importance of ongoing security awareness.
Disclaimer: This content was generated using AI. While we strive for accuracy, please verify critical information with official sources.
.webp)